IQVIA Holdings Inc (NYSE:IQV) Share Price

Company Profile

Business description
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Contact
2400 Ellis Road
DurhamNC27703
USA
T: +1 919 998-2000
E: [email protected]
https://www.iqvia.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
88,000

Recommended

Shares drop 17% after guidance is revised but we still see value.

Shane Ponraj | 09 January 2025

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Joseph Taylor | 09 January 2025

These undervalued stocks with reliable dividends are worth considering.

Susan Dziubinski | 08 January 2025

Index	Last price	Change	% Change
All Ordinaries	8,543.70	34.10	-0.40%
CAC 40	7,431.04	59.24	-0.79%
DAX 40	20,214.79	102.31	-0.50%
Dow JONES (US)	41,938.45	696.75	-1.63%
FTSE 100	8,248.49	71.20	-0.86%
HKSE	19,064.29	176.60	-0.92%
NASDAQ	19,161.63	317.25	-1.63%
Nikkei 225	39,190.40	414.69	-1.05%
NZX 50 Index	12,895.98	47.76	-0.37%
S&P 500	5,827.04	91.21	-1.54%
S&P/ASX 200	8,294.10	35.10	-0.42%
SSE Composite Index	3,168.52	42.87	-1.33%